NexGel (NXGL) Competitors $2.55 -0.02 (-0.78%) Closing price 04:00 PM EasternExtended Trading$2.56 +0.01 (+0.20%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. EDAP, PSTV, VANI, ZJYL, LUNG, GUTS, ICCM, DXR, QTI, and MDAIShould you be buying NexGel stock or one of its competitors? The main competitors of NexGel include Edap Tms (EDAP), Plus Therapeutics (PSTV), Vivani Medical (VANI), Jin Medical International (ZJYL), Pulmonx (LUNG), Fractyl Health (GUTS), IceCure Medical (ICCM), Daxor (DXR), QT Imaging (QTI), and Spectral AI (MDAI). These companies are all part of the "medical equipment" industry. NexGel vs. Its Competitors Edap Tms Plus Therapeutics Vivani Medical Jin Medical International Pulmonx Fractyl Health IceCure Medical Daxor QT Imaging Spectral AI NexGel (NASDAQ:NXGL) and EDAP TMS (NASDAQ:EDAP) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations. Is NXGL or EDAP more profitable? NexGel has a net margin of -25.02% compared to EDAP TMS's net margin of -33.49%. NexGel's return on equity of -49.37% beat EDAP TMS's return on equity.Company Net Margins Return on Equity Return on Assets NexGel-25.02% -49.37% -25.68% EDAP TMS -33.49%-56.85%-26.83% Do insiders & institutionals believe in NXGL or EDAP? 2.2% of NexGel shares are owned by institutional investors. Comparatively, 62.7% of EDAP TMS shares are owned by institutional investors. 20.6% of NexGel shares are owned by company insiders. Comparatively, 0.2% of EDAP TMS shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, NXGL or EDAP? NexGel has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, EDAP TMS has a beta of -0.15, meaning that its stock price is 115% less volatile than the S&P 500. Do analysts rate NXGL or EDAP? EDAP TMS has a consensus target price of $8.50, indicating a potential upside of 306.70%. Given EDAP TMS's stronger consensus rating and higher probable upside, analysts clearly believe EDAP TMS is more favorable than NexGel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexGel 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00EDAP TMS 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has higher valuation & earnings, NXGL or EDAP? NexGel has higher earnings, but lower revenue than EDAP TMS. NexGel is trading at a lower price-to-earnings ratio than EDAP TMS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexGel$8.69M2.37-$3.28M-$0.40-6.38EDAP TMS$69.18M1.13-$20.58M-$0.61-3.43 Does the media prefer NXGL or EDAP? In the previous week, NexGel had 4 more articles in the media than EDAP TMS. MarketBeat recorded 8 mentions for NexGel and 4 mentions for EDAP TMS. EDAP TMS's average media sentiment score of 0.79 beat NexGel's score of -0.04 indicating that EDAP TMS is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NexGel 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral EDAP TMS 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryNexGel beats EDAP TMS on 9 of the 15 factors compared between the two stocks. Get NexGel News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNexGelMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.73M$6.89B$6.04B$10.46BDividend YieldN/A1.17%5.73%4.79%P/E RatioN/A26.2185.3127.07Price / Sales2.37191.04591.31190.92Price / CashN/A21.8525.7330.17Price / Book2.835.1712.666.69Net Income-$3.28M$176.38M$3.31B$276.03M7 Day Performance0.39%-1.46%-0.44%-1.13%1 Month Performance5.81%6.91%8.70%6.49%1 Year Performance-12.07%24.74%76.70%34.41% NexGel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNexGel0.8686 of 5 stars$2.55-0.8%N/A-11.4%$20.73M$8.69M-6.3710EDAPEdap Tms2.9644 of 5 stars$2.20-3.9%$8.50+286.4%-21.0%$82.26M$69.18M-3.61230Gap DownPSTVPlus Therapeutics3.7246 of 5 stars$0.82-7.7%$8.00+874.3%-49.1%$81.51MN/A-0.3720VANIVivani Medical2.9879 of 5 stars$1.37-2.8%$4.00+192.0%+21.2%$81.16MN/A-3.0420ZJYLJin Medical InternationalN/A$0.50-11.9%N/A-83.9%$78.27M$22.83M0.00245Gap UpHigh Trading VolumeLUNGPulmonx3.2702 of 5 stars$1.73-0.6%$7.66+343.0%-76.3%$70.49M$90.55M-1.21250GUTSFractyl Health3.3091 of 5 stars$1.37-6.8%$6.90+403.6%-45.5%$68.90M$17K-0.67102Positive NewsGap UpHigh Trading VolumeICCMIceCure Medical3.0927 of 5 stars$1.000.0%$2.64+163.5%+54.4%$68.69M$3.29M-6.2560High Trading VolumeDXRDaxor3.9232 of 5 stars$13.45-2.6%$25.00+85.9%+45.4%$65.06M$3.31M0.0037Gap DownQTIQT ImagingN/A$2.39+2.5%N/A+300.7%$64.85M$4.00M0.00N/APositive NewsMDAISpectral AI2.9332 of 5 stars$2.38-1.7%$3.50+47.1%+87.4%$63.62M$27.55M-3.4583Gap UpHigh Trading Volume Related Companies and Tools Related Companies EDAP Alternatives PSTV Alternatives VANI Alternatives ZJYL Alternatives LUNG Alternatives GUTS Alternatives ICCM Alternatives DXR Alternatives QTI Alternatives MDAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexGel, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexGel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
